First Time Loading...

Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 43.24 USD -5.01% Market Closed
Updated: May 11, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.8B
+0.5%
Assets
Growth Rates:
1 Year
+39%
3 Years
+156%
5 Years
-
7 Years
-
10 Years
-
597.2m
+20%
Liabilities
Growth Rates:
1 Year
+2%
3 Years
+380%
5 Years
-
7 Years
-
10 Years
-
1.3B
-7%
Equity
Growth Rates:
1 Year
+68%
3 Years
+109%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Legend Biotech Corp

1.8B
Assets
597.2m
Liabilities
1.8B
Assets
597.2m
Liabilities
Current Assets 1.5B
Cash & Short-Term Investments 1.3B
Receivables 157.1m
Other Current Assets 31.7m
Non-Current Assets 350.8m
PP&E 189.2m
Intangibles 4.1m
Other Non-Current Assets 157.5m
Current Liabilities 216.4m
Accounts Payable 153m
Accrued Liabilities 102.4m
Other Current Liabilities -39m
Non-Current Liabilities 380.8m
Long-Term Debt 325.5m
Other Non-Current Liabilities 55.3m

Balance Sheet
Legend Biotech Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
210
83
456
689
786
1 278
Cash Equivalents
2
210
83
456
689
786
1 278
Short-Term Investments
0
6
76
50
195
241
31
Total Receivables
228
26
30
83
58
46
157
Accounts Receivables
228
26
30
75
50
0
100
Other Receivables
0
0
0
8
8
45
57
Inventory
0
1
1
2
2
10
19
Other Current Assets
1
83
22
4
6
16
12
Total Current Assets
231
327
212
594
950
1 099
1 498
PP&E Net
3
32
73
112
141
161
189
PP&E Gross
3
32
0
112
141
161
189
Accumulated Depreciation
0
1
0
11
17
25
35
Intangible Assets
0
0
1
3
5
3
4
Note Receivable
0
1
1
0
2
1
1
Other Long-Term Assets
5
69
6
13
22
67
157
Total Assets
239
N/A
429
+80%
293
-32%
722
+147%
1 120
+55%
1 331
+19%
1 849
+39%
Liabilities
Accounts Payable
4
8
81
5
7
33
153
Accrued Liabilities
8
34
0
71
101
149
102
Short-Term Debt
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
1
2
1
4
3
Other Current Liabilities
40
117
13
38
121
112
91
Total Current Liabilities
52
159
94
116
229
298
216
Long-Term Debt
0
4
5
2
122
281
325
Deferred Income Tax
0
0
42
4
0
0
0
Other Liabilities
174
257
0
3
2
8
55
Total Liabilities
227
N/A
420
+86%
141
-66%
124
-12%
354
+184%
587
+66%
597
+2%
Equity
Common Stock
0
0
0
0
0
0
0
Retained Earnings
12
9
151
598
766
744
1 251
Total Equity
12
N/A
9
-30%
151
+1 659%
598
+295%
766
+28%
744
-3%
1 251
+68%
Total Liabilities & Equity
239
N/A
429
+80%
293
-32%
722
+147%
1 120
+55%
1 331
+19%
1 849
+39%
Shares Outstanding
Common Shares Outstanding
259
259
0
0
0
330
364

See Also

Summary
LEGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
LEGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LEGN stock valuation using valuation multiples.
Wall Street Estimates
LEGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LEGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.